In the end, we assembled a library of ∼320 natural organic compounds with potential therapeutic properties (e.g., anti-cancer and anti-inflammation) and screened the library with the optimal assay condition to identify MAGL inhibitors with new chemotypes. This evidence concerns the gene MGLL and cancer.